While the expression levels of cyclin D1 increase from benign to malignant, in metastatic melanomas the expression level decreases [27] which in turn demonstrated by the clustering method clearly delineating multiple subgroups of samples in the presumably homogenous metastatic melanoma cohort. The gene discussed is CCND1; the disease is metastatic melanoma.